Javascript must be enabled to continue!
Monkeypox pandemic in Sudan, surveillance epidemiologic report, 2022
View through CrossRef
Abstract
Background
Mpox, is a zoonosis that is known to be endemic in several Central and West African countries. Recently, in 2022, it has emerged in Europe and United States, what raised the alarm to be declared in July 2022 as a public health event of international concern. This study aimed to give insight about the recent spread of mpox in Sudan, and documents the epidemiologic situation.
Methods
Through a cross-sectional design, Sudan mpox data was extracted from the disease surveillance line-list at the national level at Sudan Federal Ministry of Health. the data was customized and then analyzed using Epi Info7 software. Analysis was done using frequencies and percentages and the results presented in tables and figures. Permission and ethical approval were obtained from the Health Emergency and Epidemic Control Directorate at the Federal Ministry of Health.
Results
The outbreak of mpox was confirmed after testing of initial specimens outside Sudan with positivity rate of 72%. Later the cases continued to be reported based on the clinical diagnosis and standard case definition. Out of 375 reported cases, 54.4% were males, while 45.6% were females. The age of cases ranged from one month to 78 years with majority (41.1%) of the cases were children under 5 years of age. Regarding the reported symptoms, all cases had the characteristic skin rash and 74.1% of them had fever. Other symptoms included, headache (31.5%), sore throat (30.9%) and lymphadenopathy (26.1%). For occupation, 35.7% were preschool and 10.4% were school children, 9% of cases were prisoners. Around 22 (5.8%) reported contact history with a confirmed case, while (5.6%) of the cases were imported cases. Cases were reported from 17 states with 42 affected localities (districts) with an overall attack rate of 2.36/ 100,000. The highest number of cases was reported from Gadaref (45.3%), West Darfur (25.9%), Khartoum (13.3%) and north Darfur (3.5%). In Gadaref, 146 (85.8%) of the cases were from a refugees’ camp. Started in epi week 19, the outbreak peaked in week 38 and last in week 42.
Conclusion
Mpox was confirmed in the new Sudan for the first time with cases reported in most of states. Although importation of the virus is hypothesized, internal hidden circulation is possible and more in-depth investigation is highly recommended. The higher rate of infection among preschool, school children and refugees, highlights the need to strengthen the prevention and control measures in schools and camps. More focus on the data completeness is required for better understanding of the disease and can be ensured by the surveillance directorate through training of staff and updating of reporting forms. Strengthening the lab capacity inside the country is a necessity to ensure testing of all the clinically diagnosed cases.
Springer Science and Business Media LLC
Title: Monkeypox pandemic in Sudan, surveillance epidemiologic report, 2022
Description:
Abstract
Background
Mpox, is a zoonosis that is known to be endemic in several Central and West African countries.
Recently, in 2022, it has emerged in Europe and United States, what raised the alarm to be declared in July 2022 as a public health event of international concern.
This study aimed to give insight about the recent spread of mpox in Sudan, and documents the epidemiologic situation.
Methods
Through a cross-sectional design, Sudan mpox data was extracted from the disease surveillance line-list at the national level at Sudan Federal Ministry of Health.
the data was customized and then analyzed using Epi Info7 software.
Analysis was done using frequencies and percentages and the results presented in tables and figures.
Permission and ethical approval were obtained from the Health Emergency and Epidemic Control Directorate at the Federal Ministry of Health.
Results
The outbreak of mpox was confirmed after testing of initial specimens outside Sudan with positivity rate of 72%.
Later the cases continued to be reported based on the clinical diagnosis and standard case definition.
Out of 375 reported cases, 54.
4% were males, while 45.
6% were females.
The age of cases ranged from one month to 78 years with majority (41.
1%) of the cases were children under 5 years of age.
Regarding the reported symptoms, all cases had the characteristic skin rash and 74.
1% of them had fever.
Other symptoms included, headache (31.
5%), sore throat (30.
9%) and lymphadenopathy (26.
1%).
For occupation, 35.
7% were preschool and 10.
4% were school children, 9% of cases were prisoners.
Around 22 (5.
8%) reported contact history with a confirmed case, while (5.
6%) of the cases were imported cases.
Cases were reported from 17 states with 42 affected localities (districts) with an overall attack rate of 2.
36/ 100,000.
The highest number of cases was reported from Gadaref (45.
3%), West Darfur (25.
9%), Khartoum (13.
3%) and north Darfur (3.
5%).
In Gadaref, 146 (85.
8%) of the cases were from a refugees’ camp.
Started in epi week 19, the outbreak peaked in week 38 and last in week 42.
Conclusion
Mpox was confirmed in the new Sudan for the first time with cases reported in most of states.
Although importation of the virus is hypothesized, internal hidden circulation is possible and more in-depth investigation is highly recommended.
The higher rate of infection among preschool, school children and refugees, highlights the need to strengthen the prevention and control measures in schools and camps.
More focus on the data completeness is required for better understanding of the disease and can be ensured by the surveillance directorate through training of staff and updating of reporting forms.
Strengthening the lab capacity inside the country is a necessity to ensure testing of all the clinically diagnosed cases.
Related Results
Monkeypox Post COVID19: Knowledge, Worrying, and Vaccine Adoption of the Arabic General Population
Monkeypox Post COVID19: Knowledge, Worrying, and Vaccine Adoption of the Arabic General Population
Abstract
Background
The outbreak of monkeypox was designated a global public health emergency by the World Health Organization ...
Hydatid Disease of The Brain Parenchyma: A Systematic Review
Hydatid Disease of The Brain Parenchyma: A Systematic Review
Abstarct
Introduction
Isolated brain hydatid disease (BHD) is an extremely rare form of echinococcosis. A prompt and timely diagnosis is a crucial step in disease management. This ...
Monkeypox: In Quest of Effective Vaccines
Monkeypox: In Quest of Effective Vaccines
Purpose: The main objective of the study includes various aspects of monkeypox, its biology andtransmutability that are relevant for risk assessment and preparedness for a monkeypo...
Can Artificial Intelligence Detect Monkeypox from Digital Skin Images?
Can Artificial Intelligence Detect Monkeypox from Digital Skin Images?
Abstract
An outbreak of Monkeypox has been reported in 75 countries so far, and it is spreading at a fast pace around the world. The clinical attributes of Monkeypo...
Breast Carcinoma within Fibroadenoma: A Systematic Review
Breast Carcinoma within Fibroadenoma: A Systematic Review
Abstract
Introduction
Fibroadenoma is the most common benign breast lesion; however, it carries a potential risk of malignant transformation. This systematic review provides an ove...
Combining CNNs and Symptom Data for Improved Monkeypox Virus Detection
Combining CNNs and Symptom Data for Improved Monkeypox Virus Detection
The zoonotic disease known as monkeypox, which is related to smallpox, can be difficult to diagnose since it resembles other illnesses that might cause the same symptoms. In this s...
Monkeypox Vaccines: Current Update
Monkeypox Vaccines: Current Update
Monkeypox belonging to the genus Orthopoxvirus (OPV) of the family poxviridiae poses a major human threat even after 30 years after eradicating smallpox. OPV family includes other ...
The use of Xuanbai Chengqi decoction on monkeypox disease through the estrone-target AR interaction
The use of Xuanbai Chengqi decoction on monkeypox disease through the estrone-target AR interaction
IntroductionAfter COVID-19, there was an outbreak of a new infectious disease caused by monkeypox virus. So far, no specific drug has been found to treat it. Xuanbai Chengqi decoct...

